Skip to content

Clinical trials

Terminated Phase 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Phase: Phase 2 Status: Terminated Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20052
20061
20092
20104
20121
20161
20173

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center2
Northside Hospital, Inc.2
Alliance for Clinical Trials in Oncology1
Amit Verma1
Barbara Ann Karmanos Cancer Institute1
Eastern Cooperative Oncology Group1
Mayo Clinic1
National Cancer Institute (NCI)1
OHSU Knight Cancer Institute1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma15
Lymphoma, B-Cell, Marginal Zone9
Lymphoma, Follicular9
Leukemia, Lymphocytic, Chronic, B-Cell8
Lymphoma, Large-Cell, Anaplastic8
Lymphoma, Mantle-Cell8
Burkitt Lymphoma7
Leukemia7
Lymphoma, Large B-Cell, Diffuse7
Lymphoma, Non-Hodgkin7

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.